Pharmacology of the New P2Y12 Receptor Inhibitors: Insights on Pharmacokinetic and Pharmacodynamic Properties-Reference-Cited by-同舟云学术

Pharmacology of the New P2Y12 Receptor Inhibitors: Insights on Pharmacokinetic and Pharmacodynamic Properties

Published:2013-10 Issue:15 Volume:73 Page:1681-1709
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Ferri Nicola,Corsini Alberto,Bellosta Stefano

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s40265-013-0126-z.pdf

Reference201 articles.

1. Jennings LK. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Thromb Haemost. 2009;102(2):248–57.

2. Steinhubl SR, Moliterno DJ. The role of the platelet in the pathogenesis of atherothrombosis. Am J Cardiovasc Drugs. 2005;5(6):399–408.

3. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124(23):2574–609.

4. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345(7):494–502.

5. Angiolillo DJ, Capranzano P. Pharmacology of emerging novel platelet inhibitors. Am Heart J. 2008;156(2 Suppl):S10–5.

Cited by 120 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-time platelet P2Y12 receptor occupancy as a promising pharmacodynamics biomarker for bridging the gap between PK/PD of clopidogrel therapy;Acta Pharmaceutica Sinica B;2024-08

2. A dual-center analysis of conservative versus liberal glycoprotein IIb–IIIa antagonist strategies in the treatment of ST-elevation myocardial infarction;Scientific Reports;2024-07-01

3. Update on Perioperative Antithrombotic Management;Current Anesthesiology Reports;2024-05-15

4. Effects of myricetin and quercetin on ticagrelor metabolism and the underlying mechanism;Chemico-Biological Interactions;2024-04

5. Low-dose prasugrel versus standard-dose ticagrelor in east Asian patients with acute coronary syndrome;Journal of Thrombosis and Thrombolysis;2024-03-31